Yield10 Bioscience Announces Fourth Quarter and Full Year 2020 Financial Results
16. März 2021 16:05 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended...
Yield10 Bioscience to Present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference
11. März 2021 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announces that Chief Executive Officer Oliver Peoples, PhD. will...
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call on Tuesday, March 16, 2021
09. März 2021 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full...
Yield10 Bioscience to Present at Bank of America 2021 Virtual Global Agriculture & Materials Conference on March 4, 2021
01. März 2021 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the Bank...
Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
19. Februar 2021 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has received proceeds of approximately $3.8...
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
03. Februar 2021 12:15 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten...
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
31. Januar 2021 19:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering of...
Yield10 Bioscience Announces Proposed Public Offering of Common Stock
29. Januar 2021 16:53 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of...
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
19. Januar 2021 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced successful field testing of prototype lines of the...
Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 4th CRISPR AgBio Congress 2020 Virtual Event
02. Dezember 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that Meghna Malik, Ph.D., Senior Director, will present...